Picture of Q/C Technologies logo

QCLS — Q/C Technologies News Story

0.000.00%
us flag iconLast trade - 00:00
FinancialsSpeculativeMicro CapNeutral

Brief: Mymd Pharmaceuticals Investment Company Oravax Medical Signs Cooperation And Purchase Agreement For Initial Pre-Purchase Of 10 Million Doses Of Oral Covid-19 Vaccine To Be Commercialized In Southeast Asia

Dec 29 (Reuters) - MyMD Pharmaceuticals Inc  MYMD.O :
    * MYMD PHARMACEUTICALS INVESTMENT COMPANY ORAVAX MEDICAL
SIGNS
COOPERATION AND PURCHASE AGREEMENT FOR INITIAL PRE-PURCHASE OF
10 MILLION DOSES OF ORAL COVID-19 VACCINE TO BE COMMERCIALIZED
IN SOUTHEAST ASIA
    * MYMD PHARMACEUTICALS INC - ORAMED AND MYMD ARE CURRENTLY
EVALUATING SEVERAL OPTIONS WITH RESPECT TO THEIR INTEREST IN
ORAVAX
    * MYMD PHARMACEUTICALS INC - OPTIONS  INCLUDE A POTENTIAL
DISTRIBUTION OF ORAVAX SHARES TO BOTH ORAMED AND MYMD
SHAREHOLDERS

Source text for Eikon:  ID:nBw9spdBya 
Further company coverage:  MYMD.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Q/C Technologies

See all news